I'd give a trial adjuvant use of a CCB
All of the bolded have a propensity to increase Ca2+ (calcium ion influx, [movement into the cell] with decreased efflux [movement out of the cell]) which can increase vasoconstriction- hypertension. Unfortunately, and ARB isn't well suited in this situation.
It may be worthwhile to discuss with your treating clinician about the adjuvant use of a CCB (calcium channel blocker).